Data on sprytne.com is aggregated from official U.S. Government sources including the SEC EDGAR database, USAspending.gov, USPTO, and U.S. Census Bureau. In accordance with 17 U.S.C. § 105, works of the U.S. Government are not subject to copyright protection and reside in the Public Domain. sprytne.com provides value-added visualization and algorithmic analysis of these public records.
Not financial advice. sprytne.com is an automated market intelligence platform. We are not a registered investment advisor, broker, or dealer. Financial metrics, risk scores, and federal award data are for informational purposes only. Past performance (including government contract history) is not indicative of future market results. Verify all data via official SEC.gov filings.
This platform adheres to CCPA/GDPR standards regarding professional and public business data. Information displayed pertains to commercial entities and public officers in their professional capacity. For data verification or removal requests regarding non-public information, please visit our Contact page. Operated under Brand House Data Systems framework.
© 2026 sprytne.com — Institutional Data Intelligence — Federal Transparency Initiative
Ticker CTKB · Nasdaq · DE
Cytek Biosciences, Inc. is a U.S. business entity operating within the Laboratory Analytical Instruments sector (SIC 3826). Publicly traded on the Nasdaq under the ticker symbol CTKB, the company is incorporated in Delaware. Based on SEC EDGAR filings, CTKB reported fiscal year 2025 revenue of $201.5M, reflecting a year-over-year growth of 0.5%. Our proprietary Semantic Risk Score of 14 indicates high transparency and low reporting risk, derived from the frequency and consistency of 10-K, 10-Q, and 8-K filing patterns. As part of the SIC 3826 classification, Cytek Biosciences, Inc. serves as a key benchmark for investors and analysts monitoring Delaware corporate performance.
Comparison based on Standard Industrial Classification (SIC) mapping from SEC EDGAR filings.
Filing data sourced from SEC EDGAR signals. 10-K = annual report · 10-Q = quarterly · 8-K = material event.
Cytek Biosciences, Inc. (CTKB) — Key efficiency & solvency metrics · FY2025
Operating Margin
Sector avg: -34.34%
Net Margin
Sector avg: -48.39%
Debt-to-Equity
Sector avg: -10.39
Current Ratio
Sector avg: 3.64
| Key Metric | Company | Industry Avg | Status |
|---|---|---|---|
| Total RevenueYoY: +0.5% | $201.5M | $1.43B | ▼ Lagging |
| Net IncomeYoY: -1005.3% | $-66,539,000 | — | — |
| Operating MarginOperating income as % of revenue | -20% | -34.34% | ▲ Outperform |
| Net MarginNet income as % of revenue | -33% | -48.39% | ▲ Outperform |
| Debt-to-EquityTotal liabilities / stockholders equity. Lower = safer. | 0.35 | -10.39 | ▼ Leveraged |
| Current RatioCurrent assets / current liabilities. Above 1.0 = solvent. | 5.04 | 3.64 | ▲ Outperform |
Source: SEC EDGAR XBRL filings (10-K annual reports). Industry benchmarks derived from 23 companies in SIC 3826.
Disclaimer: All financial data is sourced from raw SEC EDGAR filings. Sprytne.com provides automated data visualization and algorithmic analysis for informational purposes only. This is NOT financial advice, a recommendation to buy/sell, or a guarantee of accuracy. Always verify data via official SEC sources before making investment decisions.
Federal Contracts
PURCHASE ORDER TO PROCURE A BRAND NAME OR EQUAL CYTEK AURORA-CS 5L FULL SPECTRUM SORTER AND AURORA 5-LASER UV/V/B/YG/R SYSTEMS FOR NIAMS' FLOW CYTOMETRY FACILITY (FCF)
CYTEK AURORA 4 AND CYTEK AURORA CS FULL SPECTRUM SORTER CYTEK AURORA CS 4
PURCHASE OF AMNIS IMAGESTREAM MKII SYSTEM
BASE PERIOD - MAINTENANCE SERVICES FOR SIX (6) CYTEK AURORA DEVICES TO MAINTAIN OPTIMAL PERFORMANCE IN SUPPORT OF THE NCI/CCR. FOUR (4) CYTEK AURORA 5 LASER W/ LOADER ; ONE (1) CYTEK AURORA 4 LASER W/ LOADER; AND ONE (1) CYTEK AURORA CELL SORTER
CYTEK FLOW CYTOMETRY ANALYSIS SYSTEM (COVID-19 RESPONSE)
ACQUISITION OF ONE (1) CYTEK AURORA CELL SORTER 5L (PRODUCT #N7-00094)
MULTIPARAMETER SPECTRAL ANALYZING FLOW CYTOMETER
CYTEK AURORA 5 LASER FLOW CYTOMETER
CYTEK AURORA 5 LASER UV/V/B/YG/R (64 + 3 CHANNEL)
PURCHASE ORDER - ONE (1) BRAND NAME CYTEK AURORA 5 LASER SPECTRAL FLOW CYTOMETER WITH AN AUTOMATED SAMPLE LOADER (ASL)- DELIVERY 30 DAYS AFTER RECEIPT OF AWARD.
Source: USAspending.gov (Official Federal Award Data). Reflects prime contracts only. Last sync: 2026-03-30.
Compared to 25 peers in Laboratory Analytical Instruments (SIC 3826)
Revenue
Net Margin
SEC EDGAR XBRL filings by fiscal year
Side-by-side financial showdown — revenue, margins, and growth.
Methodology & compliance note
Data is aggregated from SEC EDGAR and Secretary of State public records. Any analytics such as "market share" are statistical estimates (proxy models) and are not official audits, valuations, or investment advice. Sprytne.com is an independent data aggregator and is not affiliated with any government agency.Learn more →